Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Dyslipidemia

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    September 2022
  1. VALENTINE A, Davis S, Furniss A, Dowshen N, et al
    Multicenter Analysis of Cardiometabolic-related Diagnoses in Transgender and Gender-Diverse Youth: A PEDSnet Study.
    J Clin Endocrinol Metab. 2022;107:e4004-e4014.
    PubMed     Abstract available


    August 2022
  2. COSTA S, Sampaio L, Berta Sousa A, Xing C, et al
    Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2022;107:2433-2438.
    PubMed     Abstract available


    July 2022
  3. CAI X, Liang N, Cai X, Zhou Q, et al
    Lipid Metabolic Genes and Maternal Supraphysiological Hypercholesterolemia: An Analysis of Maternal-fetal Interaction.
    J Clin Endocrinol Metab. 2022;107:e3134-e3144.
    PubMed     Abstract available


  4. SHANNON CE, Merovci A, Fourcaudot M, Tripathy D, et al
    Effects of Sustained Hyperglycemia on Skeletal Muscle Lipids in Healthy Subjects.
    J Clin Endocrinol Metab. 2022;107:e3177-e3185.
    PubMed     Abstract available


  5. OSTINELLI G, Laforest S, Denham SG, Gauthier MF, et al
    Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction.
    J Clin Endocrinol Metab. 2022;107:e3330-e3342.
    PubMed     Abstract available


    June 2022
  6. DING X, Wang Y, Liu J, Wang G, et al
    Impaired sensitivity to thyroid hormones is associated with elevated homocysteine levels in the euthyroid population.
    J Clin Endocrinol Metab. 2022 Jun 16. pii: 6609259. doi: 10.1210.
    PubMed     Abstract available


    May 2022
  7. MELA V, Ruiz-Limon P, Balongo M, Rad HM, et al
    Mitochondrial Homeostasis In Obesity Related Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022 May 24. pii: 6591321. doi: 10.1210.
    PubMed     Abstract available


  8. SUBRAMANIAN S
    Approach to the Patient With Moderate Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022;107:1686-1697.
    PubMed     Abstract available


  9. FOURMAN LT, Grinspoon SK
    Approach to the Patient With Lipodystrophy.
    J Clin Endocrinol Metab. 2022;107:1714-1726.
    PubMed     Abstract available


    April 2022
  10. DAVIS SM, Nokoff NJ, Furniss A, Pyle L, et al
    Population-based Assessment of Cardiometabolic-related Diagnoses in Youth With Klinefelter Syndrome: A PEDSnet Study.
    J Clin Endocrinol Metab. 2022;107:e1850-e1859.
    PubMed     Abstract available


  11. WANG M, Xue Q, Li X, Krohn K, et al
    Circulating Levels of microRNA-122 and Hepatic Fat Change in Response to Weight-Loss Interventions: CENTRAL Trial.
    J Clin Endocrinol Metab. 2022;107:e1899-e1906.
    PubMed     Abstract available


  12. AGUILAR-SALINAS CA, Gomez-Diaz RA, Corral P
    New Therapies for Primary Hyperlipidemia.
    J Clin Endocrinol Metab. 2022;107:1216-1224.
    PubMed     Abstract available


    March 2022
  13. GUO K, Savelieff MG, Rumora AE, Alakwaa FM, et al
    Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.
    J Clin Endocrinol Metab. 2022;107:1091-1109.
    PubMed     Abstract available


  14. ZHANG S, Cheng S, He X, Wang W, et al
    Remnant Lipoprotein Cholesterol as a Factor Related to Adult Fatty Liver Disease.
    J Clin Endocrinol Metab. 2022;107:e1598-e1609.
    PubMed     Abstract available


  15. EID WE, Sapp EH, Wendt A, Lumpp A, et al
    Improving Familial Hypercholesterolemia Diagnosis Using an EMR-based Hybrid Diagnostic Model.
    J Clin Endocrinol Metab. 2022;107:1078-1090.
    PubMed     Abstract available


  16. CHUNG ST, Katz LEL, Stettler-Davis N, Shults J, et al
    The relationship between lipoproteins and insulin sensitivity in youth with obesity and abnormal glucose tolerance.
    J Clin Endocrinol Metab. 2022 Mar 3. pii: 6542083. doi: 10.1210.
    PubMed     Abstract available


    February 2022
  17. STINSON SE, Jonsson AE, Fernandez de Retana Alzola I, Lund MAV, et al
    Hyperglucagonemia in pediatric adiposity associates with cardiometabolic risk factors but not hyperglycemia.
    J Clin Endocrinol Metab. 2022 Feb 25. pii: 6537120. doi: 10.1210.
    PubMed     Abstract available


  18. MESAS AE, Garrido-Miguel M, Fernandez-Rodriguez R, Fernandez Franco S, et al
    Egg Consumption and Blood Lipid Parameters According to the Presence of Chronic Metabolic Disorders: The EVIDENT II Study.
    J Clin Endocrinol Metab. 2022;107:e963-e972.
    PubMed     Abstract available


  19. OSUNA-PRIETO FJ, Rubio-Lopez J, Di X, Yang W, et al
    Plasma Levels of Bile Acids Are Related to Cardiometabolic Risk Factors in Young Adults.
    J Clin Endocrinol Metab. 2022;107:715-723.
    PubMed     Abstract available


    January 2022
  20. PAQUETTE M, Bernard S, Pare G, Baass A, et al
    Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
    J Clin Endocrinol Metab. 2022;107:538-548.
    PubMed     Abstract available


  21. YANG R, Xu A, Kharitonenkov A
    Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver.
    J Clin Endocrinol Metab. 2022;107:e417-e419.
    PubMed    


  22. RADER DJ, Maratos-Flier E, Nguyen A, Hom D, et al
    LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2022;107:e57-e70.
    PubMed     Abstract available


    December 2021
  23. MOUSA A, Huynh K, Ellery SJ, Strauss BJ, et al
    Novel lipidomic signature associated with metabolic risk in women with and without polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2021 Dec 31. pii: 6491229. doi: 10.1210.
    PubMed     Abstract available


  24. HA J, Park SH, Park SS, Han S, et al
    Metabolic disease incidence after allogeneic stem cell transplantation: A Korean, nationwide, case-control study.
    J Clin Endocrinol Metab. 2021 Dec 14. pii: 6461117. doi: 10.1210.
    PubMed     Abstract available


    November 2021
  25. HERRERO-AGUAYO V, Saez-Martinez P, Lopez-Canovas JL, Prados-Carmona JJ, et al
    Dysregulation of Components of the Inflammasome Machinery After Bariatric Surgery: Novel Targets for a Chronic Disease.
    J Clin Endocrinol Metab. 2021;106:e4917-e4934.
    PubMed     Abstract available


  26. ASHRAF AP, Sunil B, Bamba V, Breidbart E, et al
    Case Studies in Pediatric Lipid Disorders and Their Management.
    J Clin Endocrinol Metab. 2021;106:3605-3620.
    PubMed     Abstract available


    October 2021
  27. COHEN CC, Perng W, Sundaram SS, Scherzinger A, et al
    Hepatic Fat in Early Childhood Is Independently Associated With Estimated Insulin Resistance: The Healthy Start Study.
    J Clin Endocrinol Metab. 2021;106:3140-3150.
    PubMed     Abstract available


  28. NGUYEN ML, Sachdev V, Burklow TR, Li W, et al
    Leptin Attenuates Cardiac Hypertrophy in Patients With Generalized Lipodystrophy.
    J Clin Endocrinol Metab. 2021;106:e4327-e4339.
    PubMed     Abstract available


  29. TSABAN G, Yaskolka Meir A, Zelicha H, Rinott E, et al
    Diet-induced fasting ghrelin elevation reflects the recovery of insulin sensitivity and visceral adiposity regression.
    J Clin Endocrinol Metab. 2021 Oct 13. pii: 6382201. doi: 10.1210.
    PubMed     Abstract available


    September 2021
  30. AGUILAR-RAMIREZ D, Alegre-Diaz J, Herrington WG, Staplin N, et al
    Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults.
    J Clin Endocrinol Metab. 2021;106:2828-2839.
    PubMed     Abstract available


    August 2021
  31. WANG J, Wang Z, Guo F, Zhang Y, et al
    Individual and combined cardiometabolic morbidities and the subsequent risk of cardiovascular events in Chinese adults.
    J Clin Endocrinol Metab. 2021 Aug 24. pii: 6357056. doi: 10.1210.
    PubMed     Abstract available


  32. PAQUETTE M, Amyot J, Fantino M, Baass A, et al
    Rare Variants in Triglycerides-Related Genes Increase Pancreatitis Risk in Multifactorial Chylomicronemia Syndrome.
    J Clin Endocrinol Metab. 2021;106:e3473-e3482.
    PubMed     Abstract available


    July 2021
  33. YU D, Wang Z, Zhang X, Qu B, et al
    Remnant cholesterol and cardiovascular mortality in patients with type 2 diabetes and incident diabetic nephropathy.
    J Clin Endocrinol Metab. 2021 Jul 22. pii: 6325383. doi: 10.1210.
    PubMed     Abstract available


    June 2021
  34. MIYAMURA K, Nawa N, Isumi A, Doi S, et al
    The Association of Passive Smoking and Dyslipidemia Among Adolescence in Japan: Results From A-CHILD Study.
    J Clin Endocrinol Metab. 2021;106:e2738-e2748.
    PubMed     Abstract available


    April 2021
  35. KIYA M, Tamura Y, Takeno K, Someya Y, et al
    Adipose Insulin Resistance and Decreased Adiponectin Are Correlated With Metabolic Abnormalities in Nonobese Men.
    J Clin Endocrinol Metab. 2021;106:e2228-e2238.
    PubMed     Abstract available


    March 2021
  36. BELHASSEN M, Van Ganse E, Nolin M, Berard M, et al
    10-Year Comparative Follow-up of Familial versus Multifactorial Chylomicronemia Syndromes.
    J Clin Endocrinol Metab. 2021;106:e1332-e1342.
    PubMed     Abstract available


  37. GRANT LK, Czeisler CA, Lockley SW, Rahman SA, et al
    Time-of-day and Meal Size Effects on Clinical Lipid Markers.
    J Clin Endocrinol Metab. 2021;106:e1373-e1379.
    PubMed     Abstract available


  38. YEN CL, Fan PC, Lin MS, Lee CC, et al
    Fenofibrate Delays the Need for Dialysis and Reduces Cardiovascular Risk among Patients with Advanced CKD.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156972. doi: 10.1210.
    PubMed     Abstract available


  39. MORYS F, Dadar M, Dagher A
    Association between mid-life obesity, its metabolic consequences, cerebrovascular disease and cognitive decline.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156963. doi: 10.1210.
    PubMed     Abstract available


  40. TORKY A, Sinaii N, Jha S, Desai J, et al
    Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.
    J Clin Endocrinol Metab. 2021 Mar 2. pii: 6156969. doi: 10.1210.
    PubMed     Abstract available


    February 2021
  41. STINSON SE, Jonsson AE, Lund MAV, Frithioff-Bojsoe C, et al
    Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents.
    J Clin Endocrinol Metab. 2021 Feb 17. pii: 6141463. doi: 10.1210.
    PubMed     Abstract available


  42. NGAOSUWAN K, Johnston DG, Godsland IF, Cox J, et al
    Cardiovascular disease in patients with primary and secondary adrenal insufficiency and the role of comorbidities.
    J Clin Endocrinol Metab. 2021 Feb 15. pii: 6135110. doi: 10.1210.
    PubMed     Abstract available


  43. MORAN C, McEniery CM, Schoenmakers N, Mitchell C, et al
    Dyslipidemia, insulin resistance, ectopic lipid accumulation and vascular function in Resistance to Thyroid Hormone beta.
    J Clin Endocrinol Metab. 2021 Feb 1. pii: 6125725. doi: 10.1210.
    PubMed     Abstract available


    January 2021
  44. LUUKKONEN PK, Qadri S, Lehtimaki TE, Juuti A, et al
    The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients.
    J Clin Endocrinol Metab. 2021;106:e300-e315.
    PubMed     Abstract available


    December 2020
  45. NEWMAN CB, Blaha MJ, Boord JB, Cariou B, et al
    Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    October 2020
  46. FERCHAUD-ROUCHER V, Zair Y, Aguesse A, Krempf M, et al
    Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    September 2020
  47. KOTWAL A, Cortes T, Genere N, Hamidi O, et al
    Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2020 Sep 21. pii: 5909289. doi: 10.1210.
    PubMed     Abstract available


    May 2020
  48. KOZAKOVA M, Morizzo C, Penno G, Shore AC, et al
    Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    J Clin Endocrinol Metab. 2020 May 26. pii: 5846189. doi: 10.1210.
    PubMed     Abstract available


    April 2020
  49. MORALES-PALOMO F, Ramirez-Jimenez M, Ortega JF, Moreno-Cabanas A, et al
    Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


  50. LANGSTED A, Jensen AMR, Varbo A, Nordestgaard BG, et al
    Low High-Density Lipoprotein Cholesterol to Monitor Long-Term Average Increased Triglycerides.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    March 2020
  51. FANG S, Zhang S, Huang Y, Wu Y, et al
    Evidence for associations between Th1/Th17 "hybrid" phenotype and altered lipometabolism in very severe Graves' orbitopathy.
    J Clin Endocrinol Metab. 2020 Mar 16. pii: 5805506. doi: 10.1210.
    PubMed     Abstract available


  52. HSIUNG CN, Chang YC, Lin CW, Chang CW, et al
    The Causal Relationship of Circulating Triglyceride and Glycated Hemoglobin: A Mendelian Randomization Study.
    J Clin Endocrinol Metab. 2020;105.
    PubMed     Abstract available


    January 2020
  53. KELSEY MM, Pyle L, Hilkin A, Severn CD, et al
    The impact of obesity on insulin sensitivity and secretion during pubertal progression: a longitudinal study.
    J Clin Endocrinol Metab. 2020 Jan 30. pii: 5717690. doi: 10.1210.
    PubMed     Abstract available


  54. SHAH VN, Bailey R, Wu M, Foster NC, et al
    Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry.
    J Clin Endocrinol Metab. 2020 Jan 19. pii: 5709622. doi: 10.1210.
    PubMed     Abstract available


    December 2019
  55. HIGGINS V, Omidi A, Tahmasebi H, Asgari S, et al
    Marked influence of adiposity on laboratory biomarkers in a healthy cohort of children and adolescents.
    J Clin Endocrinol Metab. 2019 Dec 17. pii: 5675353. doi: 10.1210.
    PubMed     Abstract available


  56. HIGGINS V, Asgari S, Hamilton JK, Wolska A, et al
    Postprandial dyslipidemia, hyperinsulinemia, and impaired gut peptides/bile acids in adolescents with obesity.
    J Clin Endocrinol Metab. 2019 Dec 11. pii: 5673404. doi: 10.1210.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: